Neurology

Rimegepant Shows Early Efficacy in Acute Migraine Treatment



Biohaven’s acute migraine treatment rimegepant showed numerically significant differences from placebo on pain relief, with benefit as early as 15 minutes postdose.

Source link

Related posts

New Study Offers Hope of Recovery From Spinal Cord Injury

Newsemia

Medical Xpress: Autism is associated with zinc deficiency in early development—now a study links the two

Newsemia

Teaching Teens with ADHD Money Management

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World